Susquehanna Remains Neutral on Intel (INTC) Following 3Q Results

Go back to Susquehanna Remains Neutral on Intel (INTC) Following 3Q Results

FIDO Alliance Opens Worldwide Cooperation & Liaison Program - Welcomes Associations to Partner on FIDO Standards for Universal Strong Authentication

October 13, 2015 8:02 AM EDT

MOUNTAIN VIEW, CA -- (Marketwired) -- 10/13/15 -- The FIDO (Fast IDentity Online) Alliance (https://www.fidoalliance.org/), an industry consortium launched in 2013 to revolutionize online security with open standards for simpler, stronger authentication, today introduced the FIDO Cooperation & Liaison Program, inviting associations worldwide to... More

Intec Pharma Announces Topline Results of a Food Effect, Pharmacokinetic Study of AP-CDLD 50/500mg for the Treatment of Parkinson's Disease Symptoms

October 12, 2015 9:38 PM EDT

JERUSALEM, ISRAEL -- (Marketwired) -- 10/12/15 -- Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced results of the food effect study of the Phase 3 formulation of its leading product candidate, Accordion Pill Carbidopa/Levodopa, or AP-CDLD. The results demonstrated that plasma concentrations of carbidopa and levodopa were similar, with no statistically significant differences in all PK parameters... More